RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kyowa Kirin Co - Stock

Kyowa Kirin Co Revenue 2024

Kyowa Kirin Co Revenue

482.83 B JPY

Ticker

4151.T

ISIN

JP3256000005

WKN

858523

In 2024, Kyowa Kirin Co's sales reached 482.83 B JPY, a 9.18% difference from the 442.23 B JPY sales recorded in the previous year.

The Kyowa Kirin Co Revenue history

YEARREVENUE (undefined JPY)GROSS MARGIN (%)
2026e525.3963,01
2025e496.7866,63
2024e482.8368,56
2023442.2374,85
2022398.3778,18
2021352.2575,06
2020318.3574,73
2019305.8273,97
2018271.5172,98
2017353.3863,48
2016347.9661,67
2015364.3261,87
2014333.4561,75
2013340.6162,46
2012333.1663,24
2011343.7257,48
2010413.7446,16
2009309.1145,21
2008460.1843,53
2007392.1236,96
2006354.2737,10
2005353.4435,92
2004358.9636,79

Kyowa Kirin Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Kyowa Kirin Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Kyowa Kirin Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Kyowa Kirin Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Kyowa Kirin Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Kyowa Kirin Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Kyowa Kirin Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Kyowa Kirin Co’s growth potential.

Kyowa Kirin Co Revenue, EBIT and net profit per share

DateKyowa Kirin Co RevenueKyowa Kirin Co EBITKyowa Kirin Co Net Income
2026e525.39 B undefined0 undefined83.9 B undefined
2025e496.78 B undefined98.98 B undefined71.59 B undefined
2024e482.83 B undefined94.94 B undefined67.57 B undefined
2023442.23 B undefined93.85 B undefined81.19 B undefined
2022398.37 B undefined81.39 B undefined53.57 B undefined
2021352.25 B undefined60.85 B undefined52.35 B undefined
2020318.35 B undefined58.24 B undefined47.03 B undefined
2019305.82 B undefined54.06 B undefined67.08 B undefined
2018271.51 B undefined53.88 B undefined54.41 B undefined
2017353.38 B undefined62.5 B undefined42.9 B undefined
2016347.96 B undefined52.32 B undefined30.45 B undefined
2015364.32 B undefined43.77 B undefined29.77 B undefined
2014333.45 B undefined36.17 B undefined15.9 B undefined
2013340.61 B undefined51.77 B undefined30.08 B undefined
2012333.16 B undefined52.91 B undefined24.2 B undefined
2011343.72 B undefined46.14 B undefined25.61 B undefined
2010413.74 B undefined44.19 B undefined22.2 B undefined
2009309.11 B undefined24.95 B undefined8.8 B undefined
2008460.18 B undefined44.63 B undefined11.73 B undefined
2007392.12 B undefined39.4 B undefined23.48 B undefined
2006354.27 B undefined30.71 B undefined12.69 B undefined
2005353.44 B undefined25.54 B undefined16.22 B undefined
2004358.96 B undefined33.35 B undefined17.82 B undefined

Kyowa Kirin Co stock margins

The Kyowa Kirin Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Kyowa Kirin Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Kyowa Kirin Co.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Kyowa Kirin Co's sales revenue. A higher gross margin percentage indicates that the Kyowa Kirin Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Kyowa Kirin Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Kyowa Kirin Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Kyowa Kirin Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Kyowa Kirin Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Kyowa Kirin Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Kyowa Kirin Co Margin History

Kyowa Kirin Co Gross marginKyowa Kirin Co Profit marginKyowa Kirin Co EBIT marginKyowa Kirin Co Profit margin
2026e74.85 %0 %15.97 %
2025e74.85 %19.92 %14.41 %
2024e74.85 %19.66 %13.99 %
202374.85 %21.22 %18.36 %
202278.18 %20.43 %13.45 %
202175.06 %17.27 %14.86 %
202074.73 %18.29 %14.77 %
201973.97 %17.68 %21.94 %
201872.98 %19.84 %20.04 %
201763.48 %17.69 %12.14 %
201661.67 %15.04 %8.75 %
201561.87 %12.01 %8.17 %
201461.75 %10.85 %4.77 %
201362.46 %15.2 %8.83 %
201263.24 %15.88 %7.26 %
201157.48 %13.42 %7.45 %
201046.16 %10.68 %5.36 %
200945.21 %8.07 %2.85 %
200843.53 %9.7 %2.55 %
200736.96 %10.05 %5.99 %
200637.1 %8.67 %3.58 %
200535.92 %7.23 %4.59 %
200436.79 %9.29 %4.96 %

Kyowa Kirin Co Aktienanalyse

What does Kyowa Kirin Co do?

Kyowa Kirin Co Ltd is a Japanese pharmaceutical company that was founded over 70 years ago. The company is headquartered in Tokyo and has been listed on the stock exchange since 1974. It has over 6,000 employees worldwide and conducts research and development in the fields of bioscience and biotechnology. The history of Kyowa Kirin Co Ltd began in 1949 when the company was established as Kyowa Hakko Seiyaku Co Ltd. Initially, the company primarily focused on the production of pharmaceutical products and chemicals. In the 1990s, the company expanded globally and announced a focus on researching novel drugs. Today, Kyowa Kirin Co Ltd is a leading company in bioscience and biotechnology, offering a wide range of products and services. The company is divided into several business segments, including pharmaceuticals, biopharmaceuticals, and diagnostics. Kyowa Kirin Co Ltd has a comprehensive product range, from the asthma medication Nucala to the hearing loss medication Nouriast®. Nucala is an innovative medication for the treatment of severe asthma and was approved by the FDA in 2015. The medication has proven to be highly effective in clinical studies and has the potential to improve the lives of millions of people. Another important product from Kyowa Kirin Co Ltd is the cancer medication Mogamulizumab. The medication is used for the treatment of T-cell lymphomas, a rare form of lymph node cancer. Mogamulizumab was approved in Japan in 2012 and has since proven to be an effective medication in treating T-cell lymphomas. The company also conducts research and development in the field of regenerative medicine. An example of this is the medication Regsorin, which is used for the treatment of peripheral vascular diseases. Regsorin is a biologic made from the body's own fibronectin protein and is able to strengthen and repair blood vessels and capillaries. Another important business area for Kyowa Kirin Co Ltd is diagnostics. The company produces and distributes diagnostic tests for a range of diseases, including allergies, infectious diseases, and cancer. The diagnostics division of Kyowa Kirin Co Ltd works closely with the company's other business segments to develop and market innovative diagnostic tests. Overall, Kyowa Kirin Co Ltd is an outstanding example of a pharmaceutical company specializing in the research and development of novel drugs and therapies for serious diseases. The company has an impressive history of innovation over the decades and has established itself as a leading provider in biosciences and biotechnology. With its wide product range and innovative research efforts, Kyowa Kirin Co Ltd is a key player in the global market for medical therapies and diagnostics. Kyowa Kirin Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Kyowa Kirin Co's Sales Figures

The sales figures of Kyowa Kirin Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Kyowa Kirin Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Kyowa Kirin Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Kyowa Kirin Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Kyowa Kirin Co Stock

How much revenue did Kyowa Kirin Co generate this year?

Kyowa Kirin Co has achieved a revenue of 482.83 B JPY this year.

How much was the turnover of the company Kyowa Kirin Co compared to the previous year?

The revenue of Kyowa Kirin Co has increased by 9.18% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Kyowa Kirin Co?

The revenue of Kyowa Kirin Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Kyowa Kirin Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Kyowa Kirin Co so important for investors?

The revenue of Kyowa Kirin Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Kyowa Kirin Co pay?

Over the past 12 months, Kyowa Kirin Co paid a dividend of 56 JPY . This corresponds to a dividend yield of about 2.04 %. For the coming 12 months, Kyowa Kirin Co is expected to pay a dividend of 57.97 JPY.

What is the dividend yield of Kyowa Kirin Co?

The current dividend yield of Kyowa Kirin Co is 2.04 %.

When does Kyowa Kirin Co pay dividends?

Kyowa Kirin Co pays a quarterly dividend. This is distributed in the months of July, January, July, January.

How secure is the dividend of Kyowa Kirin Co?

Kyowa Kirin Co paid dividends every year for the past 23 years.

What is the dividend of Kyowa Kirin Co?

For the upcoming 12 months, dividends amounting to 57.97 JPY are expected. This corresponds to a dividend yield of 2.11 %.

In which sector is Kyowa Kirin Co located?

Kyowa Kirin Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kyowa Kirin Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kyowa Kirin Co from 3/1/2025 amounting to 29 JPY, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.

When did Kyowa Kirin Co pay the last dividend?

The last dividend was paid out on 3/1/2025.

What was the dividend of Kyowa Kirin Co in the year 2023?

In the year 2023, Kyowa Kirin Co distributed 51 JPY as dividends.

In which currency does Kyowa Kirin Co pay out the dividend?

The dividends of Kyowa Kirin Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kyowa Kirin Co

Our stock analysis for Kyowa Kirin Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kyowa Kirin Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.